These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10682)

  • 41. [Clinical experiences with delayed action Perspiran in obstructive respratory disorders].
    Dlouhy R
    Med Welt; 1967 Aug; 33():1918-21. PubMed ID: 5590200
    [No Abstract]   [Full Text] [Related]  

  • 42. Objective functional improvement in chronic airway obstruction.
    Petty TL; Brink GA; Miller MW; Corsello PR
    Chest; 1970 Mar; 57(3):216-23. PubMed ID: 5415971
    [No Abstract]   [Full Text] [Related]  

  • 43. Ipratropium bromide aerosol in chronic bronchitis.
    Cummiskey J; Keelan P; Gray P; Cox GA
    Ir Med J; 1977 Oct; 70(15):445-7. PubMed ID: 144713
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of salbutamol and ephedrine in oral bronchodilator combinations with theophylline and hydroxyzine: their effects on asthmatics.
    Alanko K; Lahdensuo A
    Ann Clin Res; 1977 Oct; 9(5):287-91. PubMed ID: 356718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of chronic bronchitic syndrome].
    Kopp H
    Fortschr Med; 1973 Feb; 91(6):259-61. PubMed ID: 4618832
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of ipratropium bromide in obstructive lung disease.
    Mann KV; Leon AL; Tietze KJ
    Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system (author's transl)].
    Villate Navarro JI; Sobradillo Peña V; Atxotequi Iaraoligoitia V; Salaverri Nalda A; Orive Martínez C
    Med Clin (Barc); 1980 Apr; 74(7):275-9. PubMed ID: 6446008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P; Ramos Martos A; Cabrera Moreno R; Luque Leal J; Palacios Giner A
    Rev Clin Esp; 1983 Nov; 171(4):265-8. PubMed ID: 6229844
    [No Abstract]   [Full Text] [Related]  

  • 49. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
    Stauder J; Flasch CI
    Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
    [No Abstract]   [Full Text] [Related]  

  • 50. [The effect of ipratropium bromide on ciliary action (author's transl)].
    Nakhosteen JA; Wichtmann G; Petro W; Konietzko N
    Prax Klin Pneumol; 1980 Sep; 34(9):570-4. PubMed ID: 6450411
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of bronchodilatation produced by an anticholinergic (ipratropium bromide), a beta-2 adrenergic (fenoterol) and their combination in patients with chronic obstructive airway disease. An open trial.
    Guleria R; Behera D; Jindal SK
    J Assoc Physicians India; 1991 Sep; 39(9):680-2. PubMed ID: 1839993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative study of the efficacy and action duration of ipratropium bromide and atropine sulfate using His bundle-EG and tracing ECG in bradycardial arrhythmias].
    Flohr E; Bischoff KO; Hager W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():333-6. PubMed ID: 148184
    [No Abstract]   [Full Text] [Related]  

  • 53. A double blind cross-over study of maximal expiratory flows and arterial blood gas tensions in normals, asthmatics and bronchitics after salbutamol and ipratropin.
    Thiessen B; Pedersen OF
    Scand J Respir Dis Suppl; 1979; 103():170-7. PubMed ID: 155294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results of the treatment of emphysema-bronchitis with Ozothine in a new administration form].
    Scheel H; Schneider J
    ZFA (Stuttgart); 1976 Sep; 52(26):1351-5. PubMed ID: 790806
    [No Abstract]   [Full Text] [Related]  

  • 55. [Analytical results of pulmonary function following admnstration of atrovent (ipratropiumbromide)].
    Ferlinz R; Schönen J; Siller K
    Wien Med Wochenschr Suppl; 1974 Dec; 21():10-2. PubMed ID: 4614595
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of ipratropium bromide on the histamine inhalation challenge in asthmatic and bronchitic patients.
    Laitinen LA; Viljanen AA; Viljanen BC
    Scand J Respir Dis Suppl; 1979; 103():215-8. PubMed ID: 155301
    [No Abstract]   [Full Text] [Related]  

  • 57. [Long-term atrovent treatment of chronic obstructive bronchitis].
    Khristoliubova EI; Volkova LI; Shcherbakova IV
    Klin Med (Mosk); 1999; 77(12):51-2. PubMed ID: 10684219
    [No Abstract]   [Full Text] [Related]  

  • 58. Ipratropium: an alternative for bronchodilator therapy.
    Lynn MM; Holdcroft C
    Nurse Pract; 1990 May; 15(5):44-8. PubMed ID: 2140435
    [No Abstract]   [Full Text] [Related]  

  • 59. Double blind comparison of acute bronchial and ventilation-perfusion changes to atrovent and isoproterenol.
    Schlueter DP; Neumann JL
    Chest; 1978 Jun; 73(6 Suppl):982-3. PubMed ID: 150323
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of anticholinergic agents on treatment for bronchitis and emphysema.
    Gross NJ
    Am J Med; 1991 Oct; 91(4A):11S-12S. PubMed ID: 1835289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.